Miltenyi Biotec Korea Co., Ltd.

https://www.miltenyibiotec.com

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Their innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Miltenyi Biotec’s technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Their more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In their commitment to the scientific community, they also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 24 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health. *

	Start	2013-06-01 established
	Group	Miltenyi Biotec (Group)
	Industry	MACS technology (Miltenyi)
	Industry 2	reagents (bio/biochemical)
	Person	Oh, Daesuk (Miltenyi Biotec 201306– General Manager of Miltenyi Biotec Korea)

	Region	Seoul
	Country	Korea, Republic of
	Street	659 Yeoksam-dong, Petra Bldg 8F Gangnam-gu
	City	135-913 Seoul
	Tel	+82-2-555-1988
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Miltenyi Biotec B.V. & Co. KG. (2/27/24). "Press Release: Miltenyi Biotec Opens Its First Office in India and Plans to Invest in First of Its Kind Cell and Gene Therapy Center of Excellence". Hyderabad.

		Record changed: 2024-04-30